Biovation Overview

  • Founded
  • 1994
  • Status
  • Acquired/​Merged
  • Employees
  • 21
  • Latest Deal Type
  • M&A

Biovation General Information


Provider of pharmaceutical research services. The company provides antibody and protein engineering technologies.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Aberdeen
  • Scotland, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biovation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Oct-2000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Biovation’s complete valuation and funding history, request access »

Biovation Executive Team (1)

Name Title Board Seat Contact Info
Frank Carr Ph.D Chief Executive Officer & Founder
To view Biovation’s complete executive team members history, request access »

Biovation Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biovation Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Scottish Equity Partners Growth/Expansion Minority 000 0000 000000 0
To view Biovation’s complete investors history, request access »